Characteristics of Germline Non-BRCA Mutation Status of High-Risk Breast Cancer Patients in China and Correlation with High-Risk Factors and Multigene Testing Suggestions

Background: Expert consensus on BRCA1/2 genetic testing and clinical application in Chinese breast cancer patients recommends that BRCA1/2 testing should be performed in those with clinical risk factors, such as an early onset, triple-negative breast cancer (TNBC) or family history of cancer. With t...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yifan, Yao, Qianlan, Xu, Yuyin, Yu, Chengli, Zhang, Jing, Wang, Qian, Li, Jiwei, Shi, Di, Yu, Baohua, Zeng, Yupeng, Zhu, Xiaoli, Bai, Qianming, Zhou, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670232/
https://www.ncbi.nlm.nih.gov/pubmed/34917121
http://dx.doi.org/10.3389/fgene.2021.674094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670232/
https://www.ncbi.nlm.nih.gov/pubmed/34917121
http://dx.doi.org/10.3389/fgene.2021.674094

Ejemplares similares